These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2013526)

  • 1. The epidemiology of inflammatory polyradiculoneuropathy. A critical review of the distribution, characteristics and outcome of the disease. Plasmapheresis Study Group.
    Beghi E; Cornelio F; Marconi M; Rizzuto N; Tonali P
    Ital J Neurol Sci; 1991 Feb; 12(1):63-73. PubMed ID: 2013526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
    Kanbayashi T; Sonoo M
    Brain Nerve; 2015 Nov; 67(11):1388-96. PubMed ID: 26560954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood acute and chronic immune-mediated polyradiculoneuropathies.
    Rabie M; Nevo Y
    Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
    Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
    Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions.
    Blum S; McCombe PA
    J Peripher Nerv Syst; 2014 Jun; 19(2):88-103. PubMed ID: 25039604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy.
    Schmidt B; Toyka KV; Kiefer R; Full J; Hartung HP; Pollard J
    Muscle Nerve; 1996 Apr; 19(4):474-87. PubMed ID: 8622727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of acquired demyelinating polyradiculoneuropathy.
    Hughes RA
    Acta Neurol Belg; 1994; 94(2):128-32. PubMed ID: 8036880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome.
    Odaka M; Yuki N; Hirata K
    J Neurol; 2003 Aug; 250(8):913-6. PubMed ID: 12928908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Guillain-Barrè syndrome (GBS). Implementation of a register of the disease on a nationwide basis. Italian GBS Study Group.
    Beghi E; Bogliun G
    Ital J Neurol Sci; 1996 Oct; 17(5):355-61. PubMed ID: 8933229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
    Pascual-Pascual SI
    Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic inflammatory demyelinating polyradiculoneuropathy associated with central nervous system involvement--as compared to multiple sclerosis].
    Komori T; Ohtake T; Miyazaki Y; Hirose K; Tanabe H
    Rinsho Shinkeigaku; 1990 Sep; 30(9):939-43. PubMed ID: 2265502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and chronic neuropathies: new aspects of Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy, an overview and an update.
    Trojaborg W
    Electroencephalogr Clin Neurophysiol; 1998 Nov; 107(5):303-16. PubMed ID: 9872432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Maimone D; Annunziata P; Simone IL; Livrea P; Guazzi GC
    J Neuroimmunol; 1993 Aug; 47(1):55-61. PubMed ID: 8376548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute-onset chronic inflammatory demyelinating polyneuropathy: An electrodiagnostic study.
    Anadani M; Katirji B
    Muscle Nerve; 2015 Nov; 52(5):900-5. PubMed ID: 25809534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
    Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Ilyas AA; Mithen FA; Dalakas MC; Chen ZW; Cook SD
    J Neurol Sci; 1992 Jan; 107(1):111-21. PubMed ID: 1578228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS).
    van Doorn PA
    Presse Med; 2013 Jun; 42(6 Pt 2):e193-201. PubMed ID: 23628447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory neuropathies.
    Whitesell J
    Semin Neurol; 2010 Sep; 30(4):356-64. PubMed ID: 20941668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome: diagnostic criteria, epidemiology, clinical course and prognosis.
    Hallas J; Bredkjaer C; Friis ML
    Acta Neurol Scand; 1988 Aug; 78(2):118-22. PubMed ID: 3262981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.